Skip to main content
. Author manuscript; available in PMC: 2011 Jun 15.
Published in final edited form as: Cancer Res. 2010 May 25;70(12):4972–4981. doi: 10.1158/0008-5472.CAN-09-3573

Figure 2. The effects of AZD7762 on progression from S-phase in response to gemcitabine and radiation.

Figure 2

MiaPaCa-2 cells were treated as illustrated in Fig. 1A with the exception that cells were pulsed with BrdU immediately prior to radiation (t = 24 h; 7.5 Gy). At times 26, 30, and 40 hours, cells were collected for flow cytometry. Untreated MiaPaCa-2 cells had a 20 hour cell doubling time. Data in the histograms represent only the BrdU positive cells from a single experiment with the percentages of cells in G1, S, and G2/M illustrated. Data are representative of 3 independent experiments.